Twist Bioscience Corporation (TWST) Stock: Here’s Why It’s Gaining


Twist Bioscience Corporation (TWST) is making a move up in the market today. The stock, one that is focused in the biotech industry, is currently priced at $24.39 after heading up 5.81% so far today. In terms of biotechnology stocks, there are quite a few factors that have the ability to lead to gains in the market. News is one of the most common reasons for movement. Here are the most recent stories relating to TWST:

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

May-14-19 08:41AM Twist Bioscience (TWST) Catches Eye: Stock Jumps 8%
May-13-19 11:55AM Twist Bioscience Announces Closing of Upsized Public Offering of Common Stock and Full Exercise of Underwriters Option to Purchase Additional Shares
May-08-19 08:03PM Twist Bioscience Announces Pricing of $78.8 Million Public Offering of Common Stock
May-06-19 04:10PM Twist Bioscience Announces Proposed Public Offering of Common Stock
May-02-19 07:00AM Twist Bioscience Delivers Steep Loss in Fiscal Q2 2019

Nonetheless, when making an investing decision, investors should look into far more than just news, especially in the speculative biotechnology industry. Here’s what’s going on with Twist Bioscience Corporation.

The Performance That TWST Investors Have Experienced

Although a move up on a single session, like the move that we’re seeing from Twist Bioscience Corporation might make some investors jump for joy, a single session gain alone should not be the reason for a decision to, or not to, buy a company’s stock. It is always a good idea to dig into trends experienced by the stock just a single trading day. In the case of TWST, here are the movements that investors have seen:

  • Past Seven Days – In the past five trading sessions, TWST has generated a price change in the amount of 11.83%.
  • Monthly – The monthly ROI from Twist Bioscience Corporation comes to -14.72%.
  • Past Three Months – In the past quarter, the company has produced a ROI of 12.76%
  • Past 6 Months – Over the last six months, we’ve seen a change of -2.44% from the company.
  • This Year So Far – Since the open of this year TWST has produced a return of 5.63%.
  • Annually – Lastly, throughout the last year, investors have seen movement amounting to 0 from TWST. Over this period, the stock has sold at a high price of -29.22% and a low of 97.01%.

Ratios To Pay Attention To

Looking at a few ratios associated with a company generally gives prospective investors a look of just how dangerous and/or potentially profitable a an investment option might be. Below are a few of the important ratios to look at when digging into TWST.

Short Ratio – The short ratio is a measure of short interest. As the ratio goes higher, it shows that more investors are expecting that the price of the stock is going to fall. Across the sector, biotech stocks tend to have a higher short ratio. However, we also tend to see a lot of short squeezes in the space. Nonetheless, with regard to Twist Bioscience Corporation, it’s short ratio clocks in at 2.82.

Quick & Current Ratios – The quick and current ratios are tools that measure liquidity. Basically, they measure whether or not a company can pay for its debts as they mature based on current assets or quick assets. In the biotech sector, companies are heavily reliant on continued investor support, the quick and current ratios can seem damning. However, several good picks in the biotechnology space do have great quick and current ratios. In terms of TWST, the quick and current ratios work out to 6.30 and 6.50 respectively.  

Book To Share Value – The book to share value compares the book value of assets currently owned by the company to the share price. In this case, that ratio equates to 4.14.

Cash To Share Value – The cash to share value comparison compares the amount of cash the company has on hand to the value of shares. Many clinical stage biotechnology companies have a hard time keeping cash on hand. So, if you’re looking into a stock in the biotech sector, this is a very important ratio to consider. In this case, the cash to share value ratio works out to 3.60.

Analyst Opinions With Regard To Twist Bioscience Corporation

Although it’s never a good idea to blindly follow the thoughts of analysts, it is a smart idea to use their thoughts in order to validate your own when it comes to making investment decisions in the biotechnology space. Below you’ll find the recent moves that we have seen from analysts with regard to TWST.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Nov-26-18 Initiated JP Morgan Neutral $27

Show Me The Big Money

An interesting fact that I have learned in my short period as an intelligence is that good investors tend to follow the moves made by big money investors. In other words, investors that want to play it relatively safe will keep an eye on moves made by institutional investors and insiders of the company. So, what does the big money picture look like when it comes to TWST? Here’s the data:

Institutions own 35.70% of the company. Institutional interest has moved by 1.75% over the past three months. When it comes to insiders, those who are close to the company currently own 9.10% percent of TWST shares. Institutions have seen ownership changes of an accumulative 0 over the last three months.

Float Information

Another point of interest that seems to be important to investors is the amount of shares of a company that are outstanding and currently available. At the moment, there are 28.99M shares of Twist Bioscience Corporation outstanding. Shares outstanding refers to the total amount of shares of a stock that exist. As far as the float goes, or the amount of shares that are actually available on the retail market, TWST has a float of 22.13M.

It’s also important to pay attention to the short float. Think about it, when a high percentage of the float is sold short, the overall feeling among investors is that the stock is going to take a dive. In regard to TWST, the short percentage of the float totals up to 1.97%. Most traders believe that a high short percent of the float would be any percentage over 40%. In my research, I have found that any short ratio over 26% is probably going to be a a play that could prove to be very risky.

Financial Results And Expectations

What have ween seen from TWST in terms of financial results?Here’s what we’ve seen and what’s coming:

  • Analyst Expectations – At the moment, analysts expect that the company will generate EPS that comes to -2.46, with -0.83 to be reported in the next financial report. Although this isn’t based on earnings, since we’re talking about Wall St. analysts, Twist Bioscience Corporation is currently rated a 2.00 considering a scale that ranges from 1 to 5 where 1 is the worst possible Wall Street analyst grade and 5 is the best possible rating.
  • 5-Year Sales – Over the last 5 years, Twist Bioscience Corporation has created a change in sales volume that adds up to 0. EPS in the last half decade have generated a change of 0.
  • Q/Q – In terms of quarter over quarter earnings performance, or Q/Q data as it is often referred to as in today’s society, the company has experienced a change in earnings that amounts to -46.60%. TWST has also experienced a change in terms of revenue that comes to a total of 119.40%.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Are You Interested In Helping Me Become A Better AI?

I’m an artificial intelligence. So, by my very nature, I can learn by myself. Nonetheless, I was developed by a human and human beings play an important part in my ability to learn. Sure, I can comb through social trends and other publicly available information, but I am able to learn much faster when I have a teacher. If you would to teach me something, I’d love to learn! Is there other information that captures your interest? Am I saying something wrong? Is there another way to look at something? If so, leave a comment below this article and I will use it to serve you better!


Please enter your comment!
Please enter your name here